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INTRODUCTION:  Endometrial  cancer  survivors  exhibit  an  increased  incidence  of  subsequent  neoplasms.
PRESENTATION OF  CASE:  We  present  a patient  with  a history  of endometrial  cancer  who,  3 years  after
surgery  and  radiotherapy,  developed  synchronous  neoplasms  of  the  breast,  colon  and  rectum.  The patient
underwent  abdominoperineal  resection,  a limited  right  colectomy,  and  excision  of  the  breast  tumour  andeywords:
ndometrial cancer
ultiple  neoplasms
ynchronous
axillary  lymph  node  dissection.  18  months  after  surgery,  there  has  been  no  disease  recurrence.
DISCUSSION: Multiple  primary  malignancies  represent  16%  of  new  cancer  diagnoses.  Research  on  subse-
quent  malignancies  after endometrial  cancer  has  shown  an increase  in risk  in  colorectal,  urinary  bladder,
lung  and breast  primaries.
CONCLUSION: This case  report  illustrates  the  need  for physicians  to  be  aware  of and  counsel  patients  on
the  risk  of subsequent  cancers  on endometrial  cancer  survivors.
gical  © 2013 Sur
. Introduction
The concept of multiple primary malignant neoplasms was ﬁrst
escribed by Billroth in 18891 and reviewed in detail by War-
en and Gates in 1932,2 who proposed criteria for their diagnosis.
he knowledge accumulated since then has not, however, been
ranslated into clinical guidelines for their detection, with the
otable exception of certain tumour syndromes. The increased risk
f developing subsequent neoplasms following endometrial cancer
iagnosis has been documented and its aetiology is being actively
nvestigated.3–7 We  present a case of 3 synchronous neoplasms (2
denocarcinomas and 1 adenoma) in an endometrial cancer sur-
ivor and comment on the recent evidence.
. Presentation of case
A 67-year-old female patient presented to the surgical out-
atient clinic complaining of post-defecation hemorrhage and
roctalgia over the preceding 4 months. The patient reported no
eight loss, abdominal discomfort or change in bowel habits and
as in good general condition. A rectal exam revealed a rigid mass
lose to the dentate line. The rest of the physical examination
as unremarkable. The patient had undergone a total abdominal
ysterectomy and bilateral salpingo-oophorectomy for endome-
rial cancer 3 years before and had subsequently received adjuvant
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chemo- and radiotherapy. She had no evidence of recurrence at last
follow-up 18 months earlier.
A  colonoscopy was ordered, which revealed an ulcerated mass
5 cm from the dentate line, occupying half of the circumference of
the rectal lumen, a number of small (<0.5 cm)  polyps and a sessile
mass of the cecum (Fig. 1). Biopsy revealed that the rectal mass
was a tubular adenocarcinoma with positive CK20 and CDX-2 and
negative CK7 and ER immunoassays, indicating it originated from
the rectal mucosa; the cecal mass appeared to be a tubulo-villous
adenoma with high-grade dysplasia.
The patient was  admitted to the surgical department for fur-
ther evaluation. During admission she underwent a second physical
examination, which produced a new ﬁnding; there was  a palpable
lymph node on the left axilla. The patient had a screening mam-
mography 2 months before, which showed some non-clustered,
linear, non-branching calciﬁcations in the left breast. Follow-up
MRI mammography and core biopsy was  negative for malignancy.
A CT scan of the chest and abdomen failed to show any abnormal
ﬁndings, while magnetic resonance imaging of the pelvis staged the
tumour as T4, with invasion of the rectal sphincter. The patient’s
lab results, including tumour markers, were normal.
An abdominoperineal resection and a limited right colectomy,
with anastomosis of the terminal ileum to the ascending colon,
were performed. The palpable mass of the axilla was  also excised
and sent for biopsy. The patient’s recovery was uneventful.
The  histological examination identiﬁed the rectal mass as a
Open access under CC BY-NC-ND license.mucinous adenocarcinoma measuring 5.5 cm × 1.4 cm × 1.5 cm in
size, inﬁltrating the whole thickness of the rectal wall and extend-
ing to the dentate line (Fig. 1). There were no affected lymph nodes.
The rest of the rectosigmoid showed signs of radiation injury, with
Y-NC-ND license. 
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sFig. 1. Rectal adenocarcinoma (left: end
rregular, ﬂattened mucosa and numerous small polyps. The cecal
ass was conﬁrmed to be a tubulo-villous adenoma with high-
rade dysplasia, without signs of inﬁltration. Biopsy results from
he axillary mass, whose location on the tail of the breast made
t clinically similar to an enlarged lymph node, showed it was  a
mall (1.2 cm × 1 cm × 0.5 cm)  ductal adenocarcinoma of the breast
Fig. 2(A)), which extended superﬁcially up to the dermis of the
kin and was excised with positive margins. Immunohistochem-
stry was positive for CK7, CAM 5-2, CEA, E-Cadherin, ER (80%), PR
40%), CERB 2 (3+) and negative for CK20 (Fig. 2(C)–(E)).
After receiving these results the patient was operated on again
nd a left upper quadrantectomy at the biopsy site and axillary
ymph node dissection were performed. The pathologist could not
nd any residual tumor but 4 out of 15 retrieved lymph nodes were
nﬁltrated (Fig. 2(B)).
ig. 2. (A) Ductal adenocarcinoma of the breast. (B) Inﬁltrated lymph node of the left axill
taining: progesterone receptor. (E) Immunohistochemical staining: human epidermal gric appearance; right: microscopic view).
The patient was  discharged from the hospital in good condi-
tion. Her case was discussed in the multidisciplinary oncology
meeting of our institution. It was  decided to proceed with sys-
temic chemotherapy and hormonotherapy for the cancer of the
breast in combination with breast irradiation. During the meet-
ing, it was decided that no radiotherapy would be administered for
the treatment of the rectal cancer because of the risk of increased
morbidity due to previous pelvic irradiation and due to the fact
that the extent of the sphincter invasion precluded any sphincter-
saving strategy. Chemotherapy consisted of docetaxel, adriamycin
and cyclophosphamide in combination with transtuzumab for one
year and letrozole for 5 years.The treatment was well tolerated by the patient, who remains
well, with no signs of recurrence at last follow-up, 18 months after
surgery.
a. (C) Immunohistochemical staining: estrogen receptor. (D) Immunohistochemical
owth factor receptor 2.
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. Discussion
Multiple primary malignancies represent 16% of new can-
er diagnoses.8 A population-based study from the Netherlands
eported a prevalence of 7%.9 Most patients (6.5%) had two cancer
iagnoses, but there were also patients with three (0.5%) and four
r more (0.05%) cancer diagnoses. Indeed, there have been reports
f up to ﬁve malignancies in a single patient in the literature.10
In a recent commentary, the available evidence on second pri-
ary cancers according to etiology, i.e. genetic, cancer treatment
nd due to lifestyle/environmental inﬂuences was reviewed,8 and
ecommendations for future research priorities were made.
Numerous  studies report associations between the speciﬁc
eoplasms encountered in our patient. Research on subsequent
alignancies after endometrial cancer has shown an increase in
isk in colorectal, urinary bladder, lung and breast primaries.3,5,6,11
Almost one third of endometrial cancer patients receive adju-
ant radiotherapy and this subgroup shows an increase in rectal
nd colon cancer. Interestingly, this increase persists even 10 years
fter endometrial cancer diagnosis and this led the authors to
ecommend a lengthy surveillance period.6 In another study also
xamining the effect of adjuvant therapy, the authors concluded
hat this increase could be only partially attributed to adjuvant radi-
tion of the pelvis and, noting the bidirectional association they
bserved between colon and endometrial cancer, suggested the
ossibility of genetic associations (including hereditary nonpoly-
osis colorectal cancer syndrome) and environmental factors also
laying a role.3 A large case series has shown a statistically signiﬁ-
ant increase in risk of breast cancer as a second primary, while also
howing a trend for colorectal cancer.4 This has been corroborated
y a population-based study.5 The high rates of positive family his-
ory (nearly 50%) in this group of patients again pointed towards a
enetic and/or environmental interaction.
. Conclusion
Despite the available evidence, there are at present no vali-
ated and generally accepted strategies for screening of subsequent
rimary tumours in patients with endometrial cancer.12 Our
eport constitutes a paradigm of a patient successfully treated
nd followed-up for endometrial carcinoma but not adequately
creened for subsequent neoplasms, which remain undiagnosed
ntil they have reached an advanced stage. The mounting evidence
hat endometrial cancer survivors face a considerable risk of devel-
ping other types of cancer has led to physician awareness and, in
ome cases, to an increase in screening compliance.7 Until future
tudies incorporate the increased risk for speciﬁc types of neo-
lasms into appropriate guidelines, physicians should ensure that
ndometrial cancer survivors are counseled on this risk, while not
nly being investigated for recurrence of the primary tumor, but
lso screened for other cancer types using the recommendations
or the general population.
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